Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain - sprookjes - yvandenbroek - TriplyDB

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

http://www.wikidata.org/entity/Q35041376

about

Predictive factors and clinical biomarkers for treatment in patients with chronic pain caused by osteoarthritis with a central sensitisation component Repositioning of Memantine as a Potential Novel Therapeutic Agent against Meningitic E. coli-Induced Pathogenicities through Disease-Associated Alpha7 Cholinergic Pathway and RNA Sequencing-Based Transcriptome Analysis of Host Inflammatory Responses Effects of electroacupuncture in a mouse model of fibromyalgia: role of N-methyl-D-aspartate receptors and related mechanisms.Casein kinase II regulates N-methyl-D-aspartate receptor activity in spinal cords and pain hypersensitivity induced by nerve injury.Prevention of post-mastectomy neuropathic pain with memantine: study protocol for a randomized controlled trial Comparison of electroacupuncture and morphine-mediated analgesic patterns in a plantar incision-induced pain model.Estradiol modulates visceral hyperalgesia by increasing thoracolumbar spinal GluN2B subunit activity in female rats Pentoxifylline decreases allodynia and hyperalgesia in a rat model of neuropathic pain.Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.Melatonin in antinociception: its therapeutic applications.Peri-operative ketamine with the ambulatory elastometric infusion pump as an adjuvant to manage acute postoperative pain after spinal fusion in adults: a prospective randomized trial.Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.CCL-1 in the spinal cord contributes to neuropathic pain induced by nerve injury.D-serine in the midbrain periaqueductal gray contributes to morphine tolerance in rats.Antiallodynic effects of vitamin C and vitamin E in chronic post-ischemia pain rat model.Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor Inhibition of Mammalian Target of Rapamycin (mTOR) Signaling in the Insular Cortex Alleviates Neuropathic Pain after Peripheral Nerve Injury.Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?Drug repositioning: playing dirty to kill pain.Drug combinations in the treatment of neuropathic pain.Complex regional pain syndrome type I: a comprehensive review.Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.Current and Future Issues in the Development of Spinal Agents for the Management of Pain.RNA interference of GluN1 inhibits neuronal rhythmogenesis in the adult inferior olive.Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.Activation of ERK signalling by Src family kinases (SFKs) in DRG neurons contributes to hydrogen peroxide (H2O2)-induced thermal hyperalgesia.Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice.NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory.Inhibition of β-ARK1 Ameliorates Morphine-induced Tolerance and Hyperalgesia Via Modulating the Activity of Spinal NMDA Receptors.Hepatic encephalopathy induces site-specific changes in gene expression of GluN1 subunit of NMDA receptor in rat brain.Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats.Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord.Low doses of dextromethorphan have a beneficial effect in the treatment of neuropathic pain.Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability

P2860

Q26777573-FF221A17-D797-4DB8-9C99-F1669A112AB4 Q28547329-FF5D4125-92BE-4F93-AC70-8DCE5D60AF6B Q33785470-D8950DB5-2ED0-4CD5-B7B8-9DF938A3072A Q33943983-755B699D-E93D-425F-81F9-C9A2F279B9FF Q34105873-3820849A-781D-485B-8195-F377BA298CAD Q34520850-4F142B0C-6FDF-42BF-A529-5F9274583441 Q35656080-503C5945-8431-448E-AB0C-0458DBA44022 Q35832234-80F62D23-2E4D-469B-AA4B-00B603AE620D Q35962657-6F472A8D-056A-44E1-BBF4-EBC4A14AFD1F Q36067329-C5BBA8E7-BB16-443A-8988-1D9ED718D3B2 Q36128186-8E5C126D-677F-4D70-8848-4085EBD01928 Q36730701-55D9EEBF-3AEE-4546-9E6F-42E20FD1906B Q36985101-213B9556-842B-459F-9658-739344A37DF3 Q37114777-840D00A0-3C5C-4F8F-8584-6AEC097343D7 Q37399681-D99C5485-0C0B-4EF7-B88A-DBF33452D950 Q37707733-938A2356-3E71-46FC-8318-CB684539F7E7 Q37712584-34E4D56F-B990-4E40-81E9-125FA2B9DCE8 Q38029585-9F899E2B-4EF5-4A68-AB3B-0524A5D600C5 Q38170322-EC55D4D2-BA3F-477C-94C5-A985A9A6A3A9 Q38258294-40F891DE-4B28-4F10-A66F-291DF6E16DF0 Q38436270-BAD79716-B5B3-49EC-837A-F3CA64B2DEBB Q38522262-14460A94-D477-473C-B33A-2C79089D92C6 Q38727831-19D5A173-EE53-4E89-AE6C-D0533C22CBEA Q39175715-0E3F5A44-012C-4C1D-A450-FFDF07378620 Q43075742-04EA7428-636C-4965-B2C0-A091402A0F41 Q46303837-54056696-3BC2-446E-AF15-605DFADB5CC0 Q47214245-07DE4749-3BF3-40EE-BECE-88193C0087C7 Q47383734-5758003B-33C0-42B4-92B3-EAE3F85018BF Q47702437-28E23341-92BB-46C2-BD7F-C8CFDA327D9B Q48218946-3C0F40D2-9226-4D18-A877-78A92449FDF1 Q48267280-117FB2A9-955F-41C9-8307-79D7966CACC1 Q48737325-09682705-16B5-40F8-A605-C69EC907B26A Q50672736-22BBDDE4-EC48-438F-8543-B39C04D16046 Q55535831-B28AB8E4-482B-42B8-9012-88ECA8808D22 Q56890049-3E3D43DA-E692-4BB2-8462-5F92DFA1A3B2

P2860

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

http://www.wikidata.org/entity/Q35041376

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

@ast

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

@en

type

label

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

@ast

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

@en

prefLabel

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

@ast

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

@en

P1433

Q35041376-2FDC7E67-1D18-4C3B-9D8E-554073F2AA6A

P1476

Q35041376-548BD3E9-8A32-42C9-A692-BA233140F8AF

P2093

Q35041376-11D212E3-0337-4975-B297-D689A644E248

Q35041376-1F807F5B-2D59-4B55-B909-B032FCDFD186

Q35041376-AEB76AC9-61B1-45FE-B69D-87A149F499F3

P2860

Q35041376-02D1CCB6-EE27-4CF3-ABF9-69210D05D78A

Q35041376-04CF9231-7491-463C-B7F6-92BB7D4839DC

Q35041376-0647C6F7-D3A7-4E2A-A368-EB5A663F27D2

Q35041376-07BB1713-AF16-4508-8C16-033A9DFC2A21

Q35041376-0CE11CF4-923E-4456-AF0F-8D694496F6FB

Q35041376-12E7AC58-F45A-48E2-8B64-4DA1F04A3B10

Q35041376-15CBDF83-5E05-4F00-94A2-3298BA2710D3

Q35041376-1A03FD15-E244-4490-A960-D9BE02279F9E

Q35041376-1B2D8F7E-7675-45F2-9418-5EEFBB3518D7

Q35041376-1D2016DF-52B7-4E16-ACE8-13031A70A839

P304

Q35041376-AB9E3905-C19C-45CF-BEB1-8B7145128784

P31

Q35041376-F25D190A-9EFF-4355-9AB5-5DA78542E24F

P356

Q35041376-9DD4895A-8955-4CCA-82C4-1A0F8A2449D3

P407

Q35041376-2D7E2268-AF19-44C3-9453-1E322C51E4EA

P433

Q35041376-A8C7509F-6AF6-4358-9202-CF2F2D06BDA8

P478

Q35041376-ED4A832C-9CC3-4DA2-AEDA-DA3E37FBD440

P577

Q35041376-714D7F49-C13E-482C-9069-1657354222DB

P5875

Q35041376-B6B3E4AA-42F3-49A9-8371-15FCFE57183B

P698

Q35041376-7B4D52D6-AFBB-431E-8DCE-4C2C6B94F6BB

P921

Q35041376-2E269F70-3CF7-45A2-9BD4-88DF589DCD34

P932

Q35041376-41EF490B-3EED-44D1-8FC6-3B20BB77C28B

P356

P1433

Expert Review of Clinical Pharmacology

P1476

Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

@en

P2093

Hong-Yi Zhou

http://www.w3.org/2001/XMLSchema#string

Hui-Lin Pan

http://www.w3.org/2001/XMLSchema#string

Shao-Rui Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of activation of group III metabotropic glutamate receptors on spinal synaptic transmission in a rat model of neuropathic pain

Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+.

Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

Changing subunit composition of heteromeric NMDA receptors during development of rat cortex

Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand

Identification of a phosphorylation site for calcium/calmodulindependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor

Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain

Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner

Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2

P304

379-388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECP.11.17

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51231518

http://www.w3.org/2001/XMLSchema#string

P698

21686074

http://www.w3.org/2001/XMLSchema#string

P921

neuropathic pain

P932

3113704

http://www.w3.org/2001/XMLSchema#string